Literature DB >> 3117152

Inhibitors of prostaglandin dehydrogenase (Ph CL 28A and Ph CK 61A) increase output of prostaglandins from rat isolated lung.

Y S Bakhle1, J J Pankhania.   

Abstract

1 Two potent inhibitors of prostaglandin dehydrogenase (PGDH), Ph CL 28A and Ph CK 61A, have been investigated for their effects on prostaglandin catabolism and synthesis in rat isolated lung. 2 Both CL 28A (0.3 microM) and CK 61A (0.5 and 5 microM) markedly increased the survival of prostaglandin E2 (PGE2) and PGF2 alpha on a single passage through the pulmonary circulation. 3 Both inhibitors delayed the efflux of 14C following injection of [14C]-PGE2 through the pulmonary circulation. 4 Output of PGE2 and PGF2 alpha but not that of 6-oxo-PGF1 alpha from exogenous arachidonic acid (AA) was increased by CL 28A. 5 Output of all three prostaglandins from endogenous AA stimulated by calcium ionophore A23187 was increased by CL 28A. 6 With CK 61A, output of 6-oxo-PGF1 alpha from exogenous AA was not increased but that from endogenous AA was increased by either concentration of this inhibitor. 7 We conclude that it is possible to increase output of biologically active prostaglandins from lung by preventing their inactivation in situ. 8 The apparent selectivity of PGI2 synthesis from endogenous AA to potentiation by the inhibitors may have therapeutic possibilities.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3117152      PMCID: PMC1853629          DOI: 10.1111/j.1476-5381.1987.tb11311.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

1.  Metabolism of prostacyclin. Oxidation by rhesus monkey lung 15-hydroxyl prostaglandin dehydrogenase.

Authors:  J C McGuire; F F Sun
Journal:  Arch Biochem Biophys       Date:  1978-07       Impact factor: 4.013

2.  Inhibition of pulmonary prostaglandin metabolism by inhibitors of prostaglandin biotransport (probenecid and bromcresol green).

Authors:  L Z Bito; R A Baroody
Journal:  Prostaglandins       Date:  1975-10

3.  Studies of the mechanisms involved in the fate of prostacyclin (PGI2) and 6-keto-PGF1alpha in the pulmonary circulation.

Authors:  H J Hawkings; J B Smith; K C Nicolaou; T E Eling
Journal:  Prostaglandins       Date:  1978-12

4.  Sequential changes in lung metabolism, permeability, and edema after ANTU.

Authors:  B D Minty; C M Scudder; C J Grantham; J G Jones; Y S Bakhle
Journal:  J Appl Physiol (1985)       Date:  1987-02

5.  Synthesis of thromboxane B2 and prostaglandins by bovine gastric mucosal microsomes.

Authors:  M Ali; J Zamecnik; A L Cerskus; A J Stoessl; W H Barnett; J W McDonald
Journal:  Prostaglandins       Date:  1977-11

6.  Uptake and inactivation of prostaglandin E2 methyl analogues in the rat pulmonary circulation.

Authors:  Y S Bakhle; S Jancar; B J Whittle
Journal:  Br J Pharmacol       Date:  1978-02       Impact factor: 8.739

7.  Recirculation of prostacyclin (PGI2) in the dog.

Authors:  G J Dusting; S Moncada; J R Vane
Journal:  Br J Pharmacol       Date:  1978-10       Impact factor: 8.739

8.  Stimulation of endothelial cell prostacyclin production by thrombin, trypsin, and the ionophore A 23187.

Authors:  B B Weksler; C W Ley; E A Jaffe
Journal:  J Clin Invest       Date:  1978-11       Impact factor: 14.808

9.  Metabolism of vasoactive hormones in human isolated lung.

Authors:  F Al-Ubaidi; Y S Bakhle
Journal:  Clin Sci (Lond)       Date:  1980-01       Impact factor: 6.124

10.  Action of prostaglandin dehydrogenase inhibitors on prostaglandin uptake in rat isolated lung.

Authors:  Y S Bakhle
Journal:  Br J Pharmacol       Date:  1979-04       Impact factor: 8.739

View more
  1 in total

1.  Modification by steroids of pulmonary oedema and prostaglandin E2 pharmacokinetics induced by endotoxin in rats.

Authors:  T Izumi; Y S Bakhle
Journal:  Br J Pharmacol       Date:  1988-04       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.